Swiss specialty chemicals company manufacturing complex, hazardous chemical processes for pharma customers and safety-critical intermediates.
Swiss specialty chemicals company manufacturing complex, hazardous chemical processes for pharma customers and safety-critical intermediates.
Paid by pharmaceutical customers under development and supply contracts for custom chemical intermediates, the building blocks of drug ingredients; early projects bring development fees, and a successful drug turns into large, repeating volume. It is controlled by Markus Blocher and has repeatedly expanded production capacity at its Dottikon site.
In one line: A specialty pharma-chemical CDMO like a smaller Lonza (chemical side).
Moat: narrow (process know-how, regulatory licence). Rare expertise in safely running highly exothermic/hazardous chemical reactions at scale is difficult to replicate.
Headquarters: Dottikon, Switzerland · Founded: 1913
Size Dottikon ES (DESN.SW) is a Switzerland Materials company (Chemicals: Specialty) with a market value of $4.63B, the 59th largest of 155 Switzerland companies the cockpit tracks. Shares closed at CHF 282.50 on 18 Nov 2026.
Performance Over six months the shares fell 25.8%, against -10.5% for the median peer and +9.3% for the Switzerland market (cap-weighted) — 7th lowest of 20 in its peer set.
Growth Revenue grew 11.2% over the last twelve months (peer median +8.7%); the operating margin is 27.2% (peer median 12.1%).
Valuation It trades at 38.2× forward earnings against a peer median of 12.4× (4th most expensive of 21).
Price implies For today's price to make sense, revenue must grow about 13% a year for seven years (Req g). Recent delivered growth is +14%, so the hurdle is -1 pp: the price already allows for a slowdown.
Capital Return on invested capital runs 3.6 points above its cost of capital (5.5% WACC).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | CHF 428M | CHF 428M | CHF 385M | CHF 326M | CHF 319M |
| Revenue growth | — | +11% | +18% | +2% | — |
| Gross profit | CHF 138M | CHF 141M | CHF 141M | CHF 110M | CHF 125M |
| EBITDA | CHF 148M | CHF 147M | CHF 139M | CHF 110M | CHF 121M |
| Net income | CHF 104M | CHF 104M | CHF 106M | CHF 80.6M | CHF 87.7M |
| Free cash flow | CHF 29.3M | CHF 29.3M | -CHF 31.8M | -CHF 57.2M | -CHF 47.0M |
| Capital expenditure | CHF 85.3M | CHF 85.3M | CHF 127M | CHF 160M | CHF 136M |
| Total debt | n/a | CHF 130M | CHF 130M | CHF 100M | CHF 60.0M |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
| Company | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g |
|---|---|---|---|---|---|---|
| Dottikon ES DESN.SW | $4.63B | -26% | +11% | 27% | 38.2× | 13.4% |
| Lonza LONN.SW | $53.9B | +36% | -11% | 25% | 36.1× | 15.6% |
| Siegfried SFZN.SW | $3.51B | -17% | +4% | 16% | 16.8× | n/a |
| Divi's Laboratories DIVISLAB.NS | $31.3B | +60% | +22% | 34% | 73.5× | 47.1% |
| WuXi AppTec 603259.SS | $64.2B | +40% | +32% | 43% | 17.0× | 7.2% |
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | DESN.SW | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | +2.2% | -3.9% | 7th highest of 21 |
| 6-month return | -25.8% | -10.5% | 7th lowest of 20 |
| Distance from 52-week high | -28.7% | -29.0% | 11th highest of 21 |
| Revenue growth (TTM) | +11.2% | +8.7% | 10th highest of 21 |
| Operating margin | 27.2% | 12.1% | 4th highest of 21 |
| Forward P/E | 38.2× | 12.4× | 4th most expensive of 21 |
| Growth the price implies (Req g, 7 yrs) | 13.4% | 4.6% | 4th most demanding of 17 |
| Growth delivered (Del g) | +14.4% | +9.1% | 7th highest of 17 |
| Hurdle (Req g minus delivered) | -0.9 pp | -3.6 pp | 8th most demanding of 17 |
| ROIC minus cost of capital | +3.6 pp | +0.6 pp | 7th highest of 21 |
| EV / EBITDA | 25.9× | 8.3× | 2nd most expensive of 12 |
| Net debt / EBITDA | -0.5× | 1.4× | least indebted of 12 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Dottikon ES DESN.SW | Switzerland | $4.63B | -26% | +11% | 27% | 38.2× | 13.4% | +14.4% |
| Jiangsu Nata Opto-electronic Material 300346.SZ | China | $4.65B | -26% | +15% | 16% | 67.2× | 37.7% | +34.2% |
| Red Avenue New Materials 9607.HK | Hong Kong | $4.66B | n/a | +30% | 9% | 28.7× | n/a | n/a |
| Canmax Technologies 300390.SZ | China | $4.80B | -63% | +98% | 27% | 6.2× | n/a | n/a |
| Hoshine Silicon Industry 603260.SS | China | $4.85B | -35% | -7% | -6% | 39.6× | 21.1% | +18.5% |
| Far Eastern New Century 1402.TW | Taiwan | $4.39B | +2% | +5% | 7% | 11.5× | 4.7% | +4.2% |
| Methanex MX.TO | Canada | $4.93B | +10% | +31% | 23% | 6.8× | -9.5% | +7.1% |
| Tosoh 4042.T | Japan | $4.93B | -5% | +6% | 9% | 12.2× | n/a | n/a |
| Air Water 4088.T | Japan | $4.34B | +34% | +11% | 3% | 11.8× | 9.4% | +6.8% |
| Sumitomo Chemical 4005.T | Japan | $4.95B | -21% | -2% | 5% | 7.1× | 1.7% | +0.4% |
| Guangxi Huaxi Nonferrous Metal 600301.SS | China | $4.27B | -25% | +24% | 32% | 22.6× | 9.1% | +44.9% |
| Clariant CLN.SW | Switzerland | $4.20B | +35% | -7% | 10% | 16.3× | -3.3% | +0.3% |
| Zhejiang Sanmei Chemical Industry 603379.SS | China | $4.20B | -27% | +24% | 41% | 12.2× | 3.8% | +16.5% |
| GEM 002340.SZ | China | $4.12B | -35% | +2% | 7% | 14.6× | 3.5% | +24.4% |
| Zhejiang Longsheng 600352.SS | China | $5.21B | -11% | -1% | 19% | 12.6× | -6.7% | -3.1% |
| Celanese CE | United States | $5.29B | -10% | +1% | 9% | 7.8× | 6.0% | +11.0% |
| LB Group Co., Ltd. Class A 002601.SZ | China | $5.33B | -15% | +7% | 7% | 20.4× | 4.5% | +12.9% |
| Kingboard 0148.HK | Hong Kong | $5.35B | -29% | +19% | 15% | 4.6× | n/a | n/a |
| Nissan Chemical 4021.T | Japan | $5.57B | -7% | +12% | 23% | 15.7× | 8.8% | +6.0% |
| Cabot CBT | United States | $3.80B | -5% | +1% | 14% | 11.3× | -2.3% | +1.9% |
| Navin Fluorine International NAVINFLUOR.NS | India | $5.66B | +45% | +46% | 30% | 51.6× | 37.0% | +22.7% |